Tagged: non-small cell lung cancer

A big step towards personalized medicine

An agreement  in which Abbott Laboratories will develop a specific genetic test to screen non-small cell lung cancer tumors to identify potential patients for a proposed oral cancer drug  being developed by Pfizer, was hailed as an important development in the new era of personalized genomic medicine, by Avi Spira, MD.  He is Associate Professor of […]